← Eichor
Study identifier: NCT06629116 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Study on the Role of Human Serum Albumin in Large Acute Ischemic Stroke of Anterior Circulation After Thrombectomy

Condition: Cerebral Ischemia  ·  Sponsor: Tingyu-Yi

PhaseNA
Planned participants100
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

This project intends to explore the therapeutic efficacy of human serum albumin in mitigating postoperative cerebral edema and enhancing clinical outcomes following mechanical thrombectomy in patients with acute anterior circulation large-core ischemic stroke.

This description comes directly from the study's public registry record.

Talk to the study team

Tingyu Yi, Postgraduate  ·  +86-05962082582  ·  siyuyufen@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Zhangzhou Municipal HospitalZhangzhou, Fujian, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06629116